Cargando…
Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma
BACKGROUND: The prognosis of non-small cell lung cancer (NSCLC) patients has been comprehensively studied. However, the prognosis of resectable (stage I–IIIA) lung squamous cell carcinoma (LUSC) has not been thoroughly investigated at genomic and transcriptional levels. METHODS: Data of genomic alte...
Autores principales: | Liu, Yinqiang, Duan, Jin, Zhang, Fujun, Liu, Fanghao, Luo, Xiaoyu, Shi, Yunfei, Lei, Youming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942504/ https://www.ncbi.nlm.nih.gov/pubmed/36824152 http://dx.doi.org/10.2147/CMAR.S384918 |
Ejemplares similares
-
Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers
por: Lei, Youming, et al.
Publicado: (2022) -
Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
por: Duan, Jin, et al.
Publicado: (2021) -
Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma
por: Chen, Peizhan, et al.
Publicado: (2016) -
Establishing a prognostic model for metachronous second squamous cell lung cancer in patients with resected squamous cell lung cancer
por: Fu, Shen-Shen, et al.
Publicado: (2022) -
Next-Generation Sequencing Reveals High Uncommon EGFR Mutations and Tumour Mutation Burden in a Subgroup of Lung Cancer Patients
por: Guo, Gang, et al.
Publicado: (2021)